U.S., May 17 -- ClinicalTrials.gov registry received information related to the study (NCT06976008) titled 'CMV-associated Immunomodulation in Renal Transplant Patients' on May 09.
Brief Summary: Cytomegalovirus (CMV) infection has been associated with an increased risk of bacterial, fungal and viral infections in solid organ transplant recipients. The purpose of this study to evaluate if the occurrence of CMV viremia modify the ability to develop optimal immune responses against other pathogens in kidney transplant recipients (heterologous immunity). The objective of this project is to identify the immune pathways affected by CMV in the context of immunosuppression associated with kidney transplantation.
Study Start Date: July 01
Study ...